Pituitary Disorders and Osteoporosis

Various hormonal disorders can influence bone metabolism and cause secondary osteoporosis. The consequence of this is a significant increase of fracture risk. Among pituitary disorders such effects are observed in patients with Cushing's disease, hyperprolactinemia, acromegaly, and hypopituitarism. Severe osteoporosis is the result of the coexistence of some of these disorders and hypogonadism at the same time, which is quite often.

• Publication year

  2014

• Venue

  International Journal of Endocrinology

• Publication date

  2014-04-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1155/2015/206853PMID 25873948PMCID 4383139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis.

  2014cited by this paper
• Treatment of skeletal impairment in patients with endogenous hypercortisolism : when and how ?

  2014influential reference
• Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?

  2014cited by this paper
• Utility of the trabecular bone score (TBS) in secondary osteoporosis

  2014influential reference
• Secondary causes of osteoporosis.

  2013cited by this paper
• Vertebral fractures in patients with acromegaly: a 3-year prospective study.

  2013influential reference
• Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.

  2013cited by this paper
• Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study.

  2013cited by this paper
• Acromegaly has a negative influence on trabecular bone, but not on cortical bone, as assessed by high-resolution peripheral quantitative computed tomography.

  2013influential reference
• Glucocorticoid‐induced osteoporosis: lessons from Cushing's syndrome

  2013cited by this paper
• TXNIP is highly regulated in bone biopsies from patients with endogenous Cushing's syndrome and related to bone turnover.

  2012cited by this paper
• Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism

  2012influential reference
• The risk of osteopenia in premenopausal women with various sellar tumors

  2012cited by this paper
• Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects

  2012cited by this paper
• Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis.

  2011cited by this paper
• High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly.

  2011influential reference
• Prevalence of osteoporosis and vertebral fractures in acromegalic patients.

  2011cited by this paper
• High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas

  2011cited by this paper
• Vertebral fractures in males with prolactinoma

  2011influential reference
• Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal study

  2011cited by this paper
• Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence

  2010cited by this paper
• Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency.

  2010cited by this paper
• Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy

  2010influential reference
• GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies.

  2009cited by this paper
• Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender

  2008cited by this paper
• Prevalence of vertebral fractures in men with acromegaly.

  2008influential reference
• Morbidity and GH deficiency: a nationwide study.

  2007cited by this paper
• Fracture Incidence in GH‐Deficient Patients on Complete Hormone Replacement Including GH

  2007cited by this paper
• Cushing's syndrome and bone mineral density: lowest Z scores in young patients.

  2007cited by this paper
• Increased Prevalence of Radiological Spinal Deformities in Adult Patients With GH Deficiency: Influence of GH Replacement Therapy

  2006cited by this paper
• Quantitative ultrasound at the hand phalanges in patients with acromegaly.

  2006cited by this paper
• Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.

  2006influential reference
• Glucocorticoid-induced osteoporosis: an update.

  2006influential reference
• Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function

  2005cited by this paper
• Mechanisms of glucocorticoid action in bone

  2005cited by this paper
• Cushing's Syndrome and Bone

  2005cited by this paper
• Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine

  2005cited by this paper
• Prevalence of osteopenia in men with prolactinoma

  2005influential reference
• Pathogenesis of osteoporosis: concepts, conflicts, and prospects.

  2005cited by this paper
• Acromegalic axial arthropathy: a clinical case-control study.

  2004cited by this paper
• Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome.

  2003cited by this paper
• Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status

  2003cited by this paper
• Various risks of osteoporosis in patients with pituitary adenomas

  2003cited by this paper
• Fracture risk is increased in patients with GH deficiency or untreated prolactinomas – a case‐control study

  2002influential reference
• Secondary causes of osteoporosis.

  2002cited by this paper
• Quantitative Ultrasound of the Heel and Some Parameters of Bone Turnover in Patients with Acromegaly

  2002cited by this paper
• Acromegalic arthropathy.

  2001cited by this paper
• Hypogonadism in patients with acromegaly: data from the multi‐centre acromegaly registry pilot study

  2001cited by this paper
• The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density

  2001influential reference
• Effects of 6 years of growth hormone (GH) treatment on bone mineral density in GH‐deficient adults

  2001cited by this paper
• Axial bone mineral density in patients with acromegaly.

  2000cited by this paper
• Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.

  2000cited by this paper
• Clinical review 106: Amenorrheic bone loss.

  1999influential reference
• Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.

  1999cited by this paper
• Amenorrheic Bone Loss

  1999cited by this paper
• Elderly patients with adult-onset growth hormone deficiency are not osteopenic.

  1997cited by this paper
• Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.

  1997cited by this paper
• Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.

  1995cited by this paper
• Biochemical assessment of bone formation and resorption in acromegaly.

  1993influential reference
• Bone mineral density and parameters of bone metabolism in patients with acromegaly

  1993influential reference
• [Acromegalic arthropathy].

  1993cited by this paper
• Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism.

  1989cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males

  year unknowncited by this paper

• A comprehensive review and advanced biomolecule-based therapies for osteoporosis

  2024cites this paper
• Diagnosis and therapeutic approach to bone health in patients with hypopituitarism

  2024cites this paper
• Age, body composition parameters and glycaemic control contribute to trabecular bone score deterioration in acromegaly more than disease activity

  2023cites this paper
• Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study

  2023cites this paper
• An Aggressive Plurihormonal Pituitary Adenoma With Thyrotropin, Growth Hormone, and Prolactin Excess

  2023cites this paper
• Trabecular Bone Score and Osteoprotegerin as Useful Tools in the Assessment of Bone Deterioration in Acromegaly

  2022cites this paper
• Evaluation of Bone Mineral Densitometry Measurements in Newly Diagnosed Acromegaly Patients

  2022cites this paper
• Heterogeneity and Dynamics of Vasculature in the Endocrine System During Aging and Disease

  2021cites this paper
• Cephalometric predictors of abnormal sella turcica among individuals with Sheehan Syndrome: A case-control study

  2021cites this paper
• Approaches to osteoporosis in paleopathology: How did methodology shape bone loss research?

  2021cites this paper
• List of Papers

  2021cites this paper
• Evaluation of texture imaging parameters on panoramic radiographs of patients with Sheehan's syndrome: A STROBE-compliant case-control study

  2020cites this paper
• Effects of consumption of contaminated feed with 2,4-dichlorophenoxyacetic acid (2,4-D) on the rat tibia: analysis by Raman spectroscopy and mechanical properties

  2020cites this paper
• Association Between Antipsychotics and Osteoporosis Based on Real-World Data

  2020cites this paper
• A Case of Short Stature and Severe Osteoporosis in a Young Man with Oculocutaneous Albinism: Syndrome or Coincidence?

  2020cites this paper
• Simultaneous bilateral neck of femur fractures in an adolescent secondary to hypocalcaemic seizure.

  2019cites this paper
• Evaluation of bone texture imaging parameters on panoramic radiographs of patients with Sheehan’s syndrome: a STROBE-compliant case-control study

  2019cites this paper
• Sarcopenia - Endocrinological and Neurological Aspects.

  2018cites this paper
• Multiple Endocrine Neoplasia Syndromes

  2018cites this paper
• Sarcopenia – Endocrinological and Neurological Aspects

  2018cites this paper
• Recidiva de macroadenoma hipofisario posterior a tratamiento estándar

  2017cites this paper
• Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study

  2017cites this paper
• Multiple vertebral fractures in an elderly male with macroprolactinoma

  2016cites this paper
• Differential diagnosis and management of abnormal uterine bleeding due to hyperprolactinemia

  2016cites this paper
• Multiple Fractures in Patient with Graves' Disease Accompanied by Isolated Hypogonadotropic Hypogonadism

  2016cites this paper
• Two Birds with One Stone: Possible Dual-Role of Oxytocin in the Treatment of Diabetes and Osteoporosis

  2015cites this paper
• Croatian guidelines for the management of hyperprolactinemia: a viewpoint from a developing country

  2015cites this paper
• BONE HEALTH AND DISEASE Innovative Educational Services

  2014cites this paper
• Skeletal Health in Pituitary and Neuroendocrine Diseases: Prevention and Treatments of Bone Fragility

  year unknowncites this paper